Olympus 2012 Annual Report Download - page 42

Download and view the complete annual report

Please find page 42 of the 2012 Olympus annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 105

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105

In the first half of the fiscal year ended March
31, 2012, sales of mainstay gastrointestinal
endoscopes were substantially affected by the
Great East Japan Earthquake. In the second
half of the year, however, product supply was
restored and sales were strong. As a result,
full-year net sales and operating income fell
only 2% and 5% year-on-year, respectively.
Although full-year sales and profits
declined year on year as a result of
factors including the transfer of the
inkjet printer business in March 2011
and the impact of foreign exchange and
the Great East Japan Earthquake, both
sales and profits were stable when these
additional factors are excluded.
Fiscal 2012, brought higher sales of mainstay
models, nevertheless, full-year consolidated
net sales fell year on year as a result of
factors including the flooding in Thailand.
Although an operating loss was recorded,
the amount of loss decreased thanks to
improvement in the cost of sales ratio and
cost reductions.
Sales increased by 9.5% as a result
of expansion of the mobile handset
sales network and buoyant sales of
smartphones. Operating income was
nearly flat year on year, rising 0.7%, as
a result of factors including the impact
on goodwill of making ITX Corporation a
wholly owned subsidiary in March 2011.
Net sales from the Others business fell
2.3% year on year due to the impact of
worsening market conditions overseas.
Operating loss in the Others segment
increased as a result of higher R&D
costs attendant on the acquisition of a
regenerative medicine-related business.
At a Glance
Fiscal year (“Fiscal,” “FY”), the year ended/ending March 31
Business Segment
Medical Business
Life Science & Industrial Business
Imaging Business
Information & Communication
Business
Others
Business Description
Olympus has the world’s highest
market share in the gastrointestinal
endoscope field and is currently
focusing on accelerating growth
in the surgical and endotherapy
devices field and in emerging
markets.
In the life science business, Olympus
is a global market share leader for
biological microscopes. Key products
in the industrial business include
industrial microscopes, industrial
endoscopes, and ultrasonic flaw
detectors.
Olympus offers unique digital
cameras, such as PEN and OM-D
series next-generation mirrorless
interchangeable-lens cameras and
high-end, high-power zoom compact
cameras, and voice recorders that
command high market share.
Consolidated subsidiary ITX
Corporation is one of the share
leaders in the mobile handset
sales market and operates stores
all over Japan as a primary
distributor for all mobile network
operators.
The focus of new business
creation is the medical and
healthcare fields, such as bone
replacement material, and new
businesses operated by Olympus
Business Creation Corp.
Results of Operations (FY2012)
Share of Net Sales (FY2012)
41.2%
10.9%
15.1%
27.0%
5.8%
OLYMPUS 󱚈 Annual Report 2012
40